Iso-Insulin ELISA

(10-1128-01)

Kit format: 1 x 96 wells

Measurement range: 3 - 100 mU/L (0.13 - 4.35 µg/L)

Measures total insulin

Cross-reactivity with most insulin analogs

Calibrated against 1st International Reference Preparation 66/304 for human insulin.

CE/IVD labeled on select markets

Serum controls available: 10-1134-01 (US only) or 10-1164-01

TALK TO A PERSON

Description

Mercodia Iso-Insulin ELISA provides a method for the quantitative determination of total insulin.

A high quality immunoassay for the quantification of insulin; both endogenous and exogenous. The assay measures common, as well as non-commercially available, insulin analogues and comes with full cross-reactivity data. Combination of Mercodia Iso-Insulin ELISA with the highly specific Mercodia Insulin ELISA enables calculation of analog concentrations by subtracting endogenous insulin.

Mercodia Diabetes Antigen Control (10-1134-01 (US only) or 10-1164-01) is designed to be used as a two-level control for human insulin.

Test characteristics

Species

Human

Samples

Serum, plasma, cell culture medium

Sample volume

25 µL

Assay range

3 - 100 mU/L (0.13 - 4.35 µg/L)

Detection limit

≤ 2 mU/L (0.086 µg/L)

Incubation

1 h + 15 min

Detection method

Absorbance

specificity

The following cross-reactions have been tested:

Insulin

100 %

C-peptide

<0.1 %

Proinsulin

54 %

Proinsulin des (31-32)

58 %

Proinsulin split (32-33)

56 %

Proinsulin des (64-65)

66 %

Proinsulin split (65-66)

78 %

Insulin lispro

112 %

Insulin aspart

100 %

Insulin determir

28 %

Insulin glargine

58 %

Insulin glulisine

123 %

IGF-I

< 0.02 %

IGF-II

< 0.02 %

Rat insulin

71 %

Mouse insulin

49 %

Porcine insulin

76 %

Ovine insulin

131 %

Bovine insulin

58 %

directions for use Certificate of Analysis Safety Data Sheet

directions for use

LOT. NO.	DOCUMENT
35079	DfU - 10-1128-01 v. 17.0
35703	DfU - 10-1128-01 v. 17.0

Certificate of Analysis

LOT. NO.	DOCUMENT
35079	CoA - 10-1128-01
35703	CoA - 10-1128-01

Safety Data Sheet

DOCUMENT
SDS - 10-1128-01

For other languages and previous versions: Technical Library

references

Fink, H., Herbert, C., & Gilor, C. (2018). Pharmacodynamics and pharmacokinetics of insulin detemir and insulin glargine 300 U/mL in healthy dogs. Domestic Animal Endocrinology, 64, 17–30. Read more >

Regittnig, W. et al. (2019). Insulin Bolus Administration in Insulin Pump Therapy: Effect of Bolus Delivery Speed on Insulin Absorption from Subcutaneous Tissue. Diabetes Technology & Therapeutics, 21(1), 44–50. Read more >

Wang, J. et al. (2019). Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs. Science Advances, 5(7), 4357–4367. Read more >